Evidence map›Paper›PMID 30744575›Full record

ArticleBMC infectious diseases2019

Immune signatures for HIV-1 and HIV-2 induced CD4

Sukeshani Salwe, Amitkumar Singh, Varsha Padwal, Shilpa Velhal, Vidya Nagar, Priya Patil, Alaka Deshpande, Vainav Patel

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. CD39Oncoimmunology · 2023
    Article
  11. CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Review
  12. Article
  13. HIV-2: still off the radar for India's 90-90-90 targets.The Indian journal of medical research · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sukeshani SalweDepartment of Biochemistry and Virology, National Institute for Research in Reproductive Health, Indian Council of Medical Research, J. M. Street, Parel, Mumbai, 400012, India.
Amitkumar SinghDepartment of Biochemistry and Virology, National Institute for Research in Reproductive Health, Indian Council of Medical Research, J. M. Street, Parel, Mumbai, 400012, India.
Varsha PadwalDepartment of Biochemistry and Virology, National Institute for Research in Reproductive Health, Indian Council of Medical Research, J. M. Street, Parel, Mumbai, 400012, India.
Shilpa VelhalDepartment of Biochemistry and Virology, National Institute for Research in Reproductive Health, Indian Council of Medical Research, J. M. Street, Parel, Mumbai, 400012, India.
Vidya NagarDepartment of Medicine, Grant Medical College & Sir J. J. group of Hospitals, Mumbai, 400008, India.
Priya PatilDepartment of Medicine, Grant Medical College & Sir J. J. group of Hospitals, Mumbai, 400008, India.
Alaka DeshpandeDepartment of Medicine, Grant Medical College & Sir J. J. group of Hospitals, Mumbai, 400008, India.
Vainav PatelDepartment of Biochemistry and Virology, National Institute for Research in Reproductive Health, Indian Council of Medical Research, J. M. Street, Parel, Mumbai, 400012, India. vainavp@gmail.com.ORCID http://orcid.org/0000-0001-6661-3238
National Institute for Research in Reproductive Health · INGrant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals · IN

Funding

Department of Biotechnology , Ministry of Science and Technology BT/PR6202/GBP/27/383/2012
6 · The paper itself

Abstract

backgroundHIV-2 infection is characterised by a longer asymptomatic phase and slower AIDS progression than HIV-1 infection. Identifying unique immune signatures associated with HIV-2 pathogenesis may thus provide therapeutically useful insight into the management of HIV infection. This study examined the dynamics of the CD4

methodsA total of 111 participants including untreated and treated HIV infected individuals and seronegative individuals were enrolled in this study. The relative proportion of CD4

resultsBoth treated and untreated, HIV-1 and HIV-2 infected individuals showed apparent dysregulation in CD4

conclusionDysregulation of IL-2 and IL-7 homeostasis persists in CD4

Indexed as

AdolescentAdultCD4-Positive T-LymphocytesCohort StudiesDisease ProgressionFemaleFlow CytometryHIV-1HIV-2HIV InfectionsHumansInterleukin-2 Receptor alpha SubunitLymphocyte ActivationMaleMiddle AgedReceptors, Interleukin-7IL2RA protein, humanInterleukin-2 Receptor alpha Subunitinterleukin-7 receptor, alpha chainReceptors, Interleukin-7Anti-retroviral therapyCD4+T-cell subsetsCytotoxic T cellsGranzyme BHIV-2Immune activationImmune dysregulationLongitudinal analysisRegulatory T cells

Identifiers

PMID30744575
PMCPMC6371624
OpenAlexW2940790209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.